MED
Medifast, Inc. NYSE Listed Dec 30, 1993$11.04
-1.87%
vs $11.25
Mkt Cap $121.2M
52w Low $9.53
26.5% of range
52w High $15.22
50d MA $11.79
200d MA $11.72
P/E (TTM)
-6.5x
EV/EBITDA
—
P/B
0.6x
Debt/Equity
0.1x
ROE
-9.4%
P/FCF
97.1x
RSI (14)
16.30
ATR (14)
$0.38
Beta
0.56
50d MA
$11.79
200d MA
$11.72
Avg Volume
183.1K
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.
100 International Drive · Baltimore, MD 21202 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | AMC | -0.55 | -0.19 | +65.5% | 10.63 | -5.9% | +22.5% | -2.5% | +0.0% | -0.8% | -1.5% | — |
| Feb 17, 2026 | AMC | -0.76 | -0.55 | +27.6% | 10.80 | -2.8% | -0.8% | -0.8% | +0.1% | -0.3% | -1.1% | — |
| Nov 3, 2025 | AMC | -0.01 | -0.21 | -2000.0% | 11.88 | -3.5% | +0.8% | +1.7% | -3.1% | +1.1% | -1.2% | — |
| Aug 4, 2025 | AMC | -0.30 | 0.04 | +113.3% | 13.51 | +0.0% | -3.3% | -0.8% | -1.7% | +0.9% | -0.2% | — |
| Apr 28, 2025 | AMC | -0.07 | -0.11 | -57.1% | 12.58 | -4.4% | -0.6% | +5.1% | -1.2% | +2.1% | -1.1% | — |
| Feb 18, 2025 | AMC | -0.16 | 0.10 | +162.5% | 16.13 | -2.0% | -11.4% | +0.3% | +2.8% | +0.3% | -2.6% | — |
| Nov 4, 2024 | AMC | -0.15 | 0.35 | +333.3% | 18.81 | +10.6% | +8.5% | -3.4% | +0.9% | -3.6% | +1.4% | — |
| Aug 5, 2024 | AMC | 0.36 | 0.92 | +155.6% | 20.86 | -6.5% | -2.8% | -1.8% | -0.8% | -1.1% | -1.1% | — |
| Apr 29, 2024 | AMC | 0.78 | 0.66 | -15.4% | 35.51 | -25.1% | -22.5% | -4.2% | -1.6% | +2.9% | -5.7% | — |
| Feb 20, 2024 | AMC | 0.99 | 1.09 | +10.1% | 48.93 | -9.1% | -17.5% | -0.9% | +1.8% | -0.4% | +2.9% | — |
| Nov 6, 2023 | AMC | 1.07 | 2.12 | +98.1% | 70.66 | -2.2% | -2.5% | -4.3% | -1.6% | +0.9% | -4.9% | — |
| Aug 7, 2023 | AMC | 1.44 | 2.77 | +92.4% | 96.09 | +4.1% | -6.9% | +3.7% | -1.4% | +2.7% | -1.5% | — |
| May 1, 2023 | AMC | 2.40 | 3.67 | +52.9% | 90.57 | -6.4% | -2.7% | -3.4% | +3.4% | +3.2% | -1.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $10.71 | $10.50 | -2.0% | -0.8% | +0.1% | -0.3% | -1.1% | +1.6% |
| Feb 19 | DA Davidson | Maintains | Neutral → Neutral | — | $16.13 | $15.80 | -2.0% | -11.4% | +0.3% | +2.8% | +0.3% | -2.6% |
| Nov 5 | DA Davidson | Upgrade | Underperform → Neutral | — | $18.81 | $20.80 | +10.6% | +8.5% | -3.4% | +0.9% | -3.6% | +1.4% |
| Jul 22 | DA Davidson | Maintains | Underperform → Underperform | — | $18.64 | $18.81 | +0.9% | +1.4% | -0.9% | +0.6% | +3.7% | +4.9% |
| Jun 5 | DA Davidson | Downgrade | Neutral → Underperform | — | $23.97 | $20.43 | -14.8% | -8.1% | -0.8% | -1.8% | -1.9% | +2.0% |
| Apr 30 | DA Davidson | Maintains | Neutral → Neutral | — | $35.51 | $26.60 | -25.1% | -22.5% | -4.2% | -1.6% | +2.9% | -5.7% |
| Feb 21 | DA Davidson | Maintains | Neutral → Neutral | — | $48.93 | $44.49 | -9.1% | -17.5% | -0.9% | +1.8% | -0.4% | +2.9% |
| Aug 8 | DA Davidson | Maintains | Neutral → Neutral | — | $96.09 | $100.00 | +4.1% | -6.9% | +3.7% | -1.4% | +2.7% | -1.5% |
| Jul 31 | DA Davidson | Maintains | Neutral → Neutral | — | $107.06 | $107.40 | +0.3% | -4.8% | -1.9% | +1.3% | -0.9% | -1.6% |
| May 2 | DA Davidson | Maintains | Neutral → Neutral | — | $90.57 | $84.77 | -6.4% | -2.7% | -3.4% | +3.4% | +3.2% | -1.4% |
| Feb 22 | DA Davidson | Maintains | Neutral → Neutral | — | $105.44 | $101.10 | -4.1% | -2.4% | +5.6% | +1.3% | +1.6% | +0.4% |
| Nov 4 | DA Davidson | Downgrade | Buy → Neutral | — | $103.38 | $96.37 | -6.8% | +4.1% | -0.7% | +2.3% | -4.7% | +10.1% |
| Aug 4 | Jefferies | Downgrade | Buy → Hold | — | $171.60 | $150.54 | -12.3% | -13.7% | -6.3% | -1.7% | -7.7% | +2.0% |
| Aug 4 | DA Davidson | Maintains | Buy → Buy | — | $171.60 | $150.54 | -12.3% | -13.7% | -6.3% | -1.7% | -7.7% | +2.0% |
| Jun 2 | DA Davidson | Maintains | Buy → Buy | — | $174.81 | $180.36 | +3.2% | +8.4% | -2.8% | +0.0% | +2.8% | +0.0% |
| Feb 24 | DA Davidson | Maintains | Buy → Buy | — | $176.16 | $169.56 | -3.7% | -2.0% | +3.1% | +4.5% | +3.7% | -0.2% |
| Nov 8 | DA Davidson | Maintains | Buy → Buy | — | $222.19 | $222.20 | +0.0% | -1.1% | +2.0% | -0.7% | +2.6% | -0.5% |
| May 5 | DA Davidson | Maintains | Buy → Buy | — | $225.00 | $248.78 | +10.6% | +12.1% | +5.8% | +4.2% | +5.9% | -0.2% |
| Feb 26 | DA Davidson | Maintains | Buy → Buy | — | $254.75 | $250.35 | -1.7% | -0.7% | +5.1% | -1.7% | -2.7% | -5.8% |
| Jan 25 | Jefferies | Upgrade | Hold → Buy | — | $220.87 | $227.34 | +2.9% | +8.7% | +1.2% | -1.0% | -1.2% | -1.2% |
| Jan 12 | DA Davidson | Maintains | Buy → Buy | — | $207.43 | $208.00 | +0.3% | +0.6% | +2.4% | +1.0% | -3.3% | +6.4% |
| Nov 5 | DA Davidson | Upgrade | Neutral → Buy | — | $160.90 | $167.73 | +4.2% | +4.7% | +3.0% | -7.7% | +1.9% | +4.2% |
| Jun 25 | B. Riley FBR | Maintains | Buy → Buy | — | $123.01 | $124.68 | +1.4% | +6.5% | +0.4% | +3.8% | +1.6% | +1.8% |
| May 6 | DA Davidson | Maintains | Neutral → Neutral | — | $75.33 | $82.86 | +10.0% | +15.6% | +5.4% | +4.1% | -5.3% | -3.9% |
| Feb 27 | DA Davidson | Maintains | Neutral → Neutral | — | $94.48 | $81.11 | -14.2% | -9.2% | -3.2% | -1.0% | -1.5% | +1.8% |
| Nov 8 | DA Davidson | Downgrade | Buy → Neutral | — | $102.00 | $67.00 | -34.3% | -27.1% | +8.4% | -0.9% | +0.1% | -4.2% |
| Jul 25 | Jefferies | Maintains | Buy → Buy | — | $113.22 | $114.36 | +1.0% | +1.5% | -0.3% | -1.4% | -0.8% | -0.3% |
| Feb 27 | Sidoti & Co. | Maintains | Buy → Buy | — | $131.72 | $141.00 | +7.0% | -2.3% | -1.0% | -0.7% | +1.7% | +3.2% |
| Nov 8 | Sidoti & Co. | Upgrade | Neutral → Buy | — | $153.31 | $156.98 | +2.4% | +0.8% | +3.4% | -1.2% | +2.6% | -3.4% |
| May 24 | DA Davidson | Maintains | Buy → Buy | — | $136.80 | $138.98 | +1.6% | +3.0% | -0.2% | +2.2% | +1.8% | +0.2% |
| Apr 19 | Sidoti & Co. | Downgrade | Buy → Neutral | — | $102.84 | $102.11 | -0.7% | -5.6% | +1.9% | -0.9% | +1.8% | +0.0% |
| Sep 15 | DA Davidson | Maintains | Buy → Buy | — | $54.82 | $56.00 | +2.2% | +3.0% | +2.9% | -0.8% | -0.2% | -2.3% |
| Aug 17 | DA Davidson | Maintains | Buy → Buy | — | $51.63 | $51.98 | +0.7% | +8.0% | +0.1% | -0.3% | +0.2% | -0.9% |
| Jan 29 | Wunderlich | Maintains | Hold → Hold | — | $28.68 | $28.42 | -0.9% | +1.2% | -0.8% | +0.3% | -3.2% | -1.0% |
| Nov 30 | Sidoti & Co. | Downgrade | Buy → Neutral | — | $31.84 | $30.85 | -3.1% | -4.8% | -1.0% | +1.1% | -1.5% | -0.1% |
| Oct 5 | Sidoti & Co. | Upgrade | Neutral → Buy | — | $27.02 | $28.03 | +3.7% | +7.3% | -2.9% | +2.6% | -0.1% | -0.1% |
| Mar 3 | BofA Securities | Downgrade | Neutral → Underperform | — | $32.35 | $32.11 | -0.7% | -1.3% | +0.1% | -1.9% | -0.0% | -0.3% |
| Nov 7 | Imperial Capital | Downgrade | Outperform → In Line | — | $32.81 | $30.58 | -6.8% | -9.3% | +0.7% | -1.4% | +2.0% | -1.2% |
| Nov 6 | Canaccord Genuity | Maintains | Hold → Hold | — | $30.09 | $31.26 | +3.9% | +9.0% | -9.3% | +0.7% | -1.4% | +2.0% |
| Aug 11 | Imperial Capital | Maintains | Outperform → Outperform | — | $26.15 | $26.24 | +0.3% | +2.8% | -2.3% | +0.3% | +2.2% | +0.8% |
| Jun 12 | Canaccord Genuity | Maintains | Hold → Hold | — | $32.26 | $32.43 | +0.5% | +2.0% | +3.4% | +0.2% | -1.3% | -1.3% |
| Apr 23 | Imperial Capital | Maintains | Outperform → Outperform | — | $32.77 | $32.90 | +0.4% | -1.3% | +0.8% | -2.8% | -0.6% | -0.3% |
| Sep 6 | Imperial Capital | Maintains | Outperform → Outperform | — | $25.77 | $26.24 | +1.8% | -1.0% | +2.5% | -0.8% | -0.7% | +1.2% |
| Mar 26 | Wedbush | Maintains | Outperform → Outperform | — | $22.64 | $22.64 | +0.0% | -0.9% | -0.3% | +2.5% | -3.0% | +4.0% |
| Dec 19 | Canaccord Genuity | Maintains | Hold → Hold | — | $31.25 | $31.57 | +1.0% | +1.5% | +0.7% | -7.1% | -1.1% | -13.1% |
| Dec 19 | Wedbush | Maintains | Outperform → Outperform | — | $31.25 | $31.57 | +1.0% | +1.5% | +0.7% | -7.1% | -1.1% | -13.1% |
| Aug 20 | Wedbush | Maintains | Outperform → Outperform | — | $28.87 | $28.86 | -0.0% | -1.2% | -1.9% | +1.0% | -1.2% | +0.9% |
| May 9 | Sidoti & Co. | Upgrade | Neutral → Buy | — | $17.87 | $15.56 | -12.9% | -6.5% | +4.1% | +4.5% | +0.1% | -0.2% |
| May 9 | Wedbush | Maintains | Outperform → Outperform | — | $17.87 | $15.56 | -12.9% | -6.5% | +4.1% | +4.5% | +0.1% | -0.2% |
| Apr 10 | Canaccord Genuity | Maintains | Hold → Hold | — | $18.35 | $18.32 | -0.2% | -1.6% | +4.4% | +0.6% | +1.1% | +2.1% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | SCHLACKMAN SCOTTDir | — | Buy | 2,500 | $12.53 | $31K | 30,548 | -0.72% | +1.12% |
| May 8, 2026 | SCHLACKMAN SCOTTDir | — | Buy | 2,500 | $12.65 | $32K | 28,048 | -0.72% | +1.12% |
8-K · 5.02
!!! Very High
Medifast, Inc. -- 8-K 5.02: Executive Change
Medifast's Chief Legal Officer and Corporate Secretary is departing under a separation agreement, potentially creating leadership uncertainty and requiring the company to identify replacement legal oversight.
Jun 1
8-K · 5.02
!!! Very High
Medifast, Inc. -- 8-K 5.02: Executive Change
May 26
8-K · 2.02
!! High
Medifast, Inc. -- 8-K 2.02: Earnings Results
Medifast reported first-quarter 2026 earnings, providing investors with updated financial performance metrics and operational results for the company's direct-to-consumer weight-loss business segment.
May 4
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
New leadership at MED could signal strategic shifts in operations and capital allocation, making it crucial for investors to assess whether the replacement strengthens or weakens management quality.
Mar 20
8-K
Medifast, Inc. -- 8-K Filing
Medifast's return to positive coach productivity growth in Q4 2025 signals potential recovery momentum, as this metric historically precedes broader business improvement for the direct-sales wellness company.
Feb 17
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Renaissance Technologies Llc | 773,710 | $8M | Reduced | Mar 2026 |
| 2 | Morgan Stanley | 669,716 | $7M | Reduced | Dec 2025 |
| 3 | Vanguard Capital Management Llc | 444,467 | $5M | New | Mar 2026 |
| 4 | Two Sigma Investments, Lp | 338,158 | $3M | Added | Mar 2026 |
| 5 | Man Group Plc | 236,212 | $2M | — | Mar 2026 |
| 6 | Peapod Lane Capital Llc | 219,063 | $2M | Added | Mar 2026 |
| 7 | Vanguard Portfolio Management Llc | 202,829 | $2M | New | Mar 2026 |
| 8 | D.e. Shaw & Co | 160,564 | $2M | Reduced | Mar 2026 |
| 9 | Aqr Capital Management Llc | 145,575 | $1M | Added | Mar 2026 |
| 10 | Prescott Group Capital Management, L.l.c. | 111,244 | $1M | Added | Dec 2025 |
| 11 | Northern Trust Corp | 92,595 | $944K | Added | Mar 2026 |
| 12 | Bank Of America Corp /de/ | 88,777 | $905K | Reduced | Mar 2026 |
| 13 | Jpmorgan Chase & Co | 87,178 | $871K | Added | Mar 2026 |
| 14 | Divisadero Street Capital Management, Lp | 79,839 | $814K | — | Mar 2026 |
| 15 | Atom Investors Lp | 61,075 | $622K | Added | Mar 2026 |
| 16 | Quantinno Capital Management Lp | 56,153 | $572K | Added | Mar 2026 |
| 17 | Commons Capital, Llc | 38,000 | $387K | — | Mar 2026 |
| 18 | Victory Capital Management Inc | 34,302 | $350K | Reduced | Mar 2026 |
| 19 | Bank Of New York Mellon Corp | 34,291 | $349K | Reduced | Mar 2026 |
| 20 | Invesco Ltd. | 32,776 | $334K | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$121.2M
Enterprise Value
-$40.0M
P/E (TTM)
-6.49x
Forward P/E
—
PEG Ratio
0.01x
P/B
0.61x
P/S
0.31x
P/FCF
97.06x
EV/EBITDA
—
Shares Out
11.0M
Financials (TTM)
Revenue
$385.8M
Net Income
-$18.7M
EBITDA
-$3.7M
Free Cash Flow
$1.2M
Op Cash Flow
$6.9M
EPS Basic
$-1.70
EPS Diluted
$-1.70
EPS Forward
$-2.03
Gross Margin
71.3%
Op Margin
-3.7%
Net Margin
-4.8%
Balance Sheet
Total Assets
$257.0M
Total Liab.
$58.1M
Total Equity
$198.9M
Cash
$167.3M
LT Debt
$6.1M
Book Value/Sh
$18.11
Debt/Equity
0.08x
Current Ratio
4.69
Quick Ratio
4.22
Returns & Growth
ROE
-9.4%
ROA
-7.5%
ROIC
-6.5%
Rev Growth YoY
-36.0%
EPS Growth YoY
-994.7%
Price Returns
2W
-0.5%
1M
+15.3%
3M
+19.0%
6M
+14.2%
12M
-10.9%
Technicals
52W High
$15.22
52W Low
$9.53
50d MA
$11.79
200d MA
$11.72
RSI (14)
16.30
ATR (14)
$0.38
Beta
0.56
Avg Volume
183K
Dividends
Div Rate
$0.02
Div Yield
0.2%
Frequency
4
Ex-Div Date
Sep 18, 2023
Analyst Price Targets
Consensus
$12.00
High
$12.00
Low
$12.00
Median
$12.00
Data updated apr 26, 2026 11:47am
· Source: financialmodelingprep.com